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Chronic diarrhoea in children shows an age related spectrum. In
infants and young children a major role is related to persistent
intestinal infections, intolerance to speciﬁc nutrients such as cow’s
milk protein, and toddler’s diarrhoea. In older children and
adolescents, inﬂammatory bowel diseases are strongly increasing
and nonspeciﬁc diarrhoea is also frequent. Coeliac disease is
a major cause of diarrhoea throughout childhood. In neonates,
congenital diarrhoea is a rare but severe syndrome that includes
several highly complex diseases. In children, diagnosis should be
based on noninvasive techniques. Endoscopy should be decided
based on clinical criteria, but also driven by noninvasive tests to
assess the digestive absorptive functions and intestinal inﬂam-
mation. A stepwise approach may reduce the need of endoscopy,
also in the light of its relatively limited diagnostic yield compared
to adult patients. Treatment of chronic diarrhoea in children is also
substantially different from what is generally done in adults and
includes a major role for nutritional interventions. Therefore
chronic diarrhoea in children is a complex age-speciﬁc disorder
that requires an age-speciﬁc management that is in many aspects
distinct from that in adults.
 2012 Elsevier Ltd. All rights reserved.Introduction
Chronic diarrhoea refers to the persistence of loose stools (generally with an increase in stool
frequency) for at least 14 days [1]. Deﬁnitions such as ‘persistent’ or ‘protracted’ diarrhoea are lessd. All rights reserved.
A. Guarino et al. / Best Practice & Research Clinical Gastroenterology 26 (2012) 649–661650consistent in terms of duration, and generally refer to an acute-onset diarrhoea that runs a course
longer than expected.
The etiologic spectrum of chronic diarrhoea in children is substantially different from that observed
in adults and changes with age evenwithin infancy and childhood. Diarrhoea associated with cancer is
extremely rare in childhood, whereas – conversely-congenital diarrhoea occurs exclusively in early
infancy. Several diseases are common to adults and children, but may have different deﬁnitions and
presentations. The best example is chronic nonspeciﬁc diarrhoea, which is the paediatric counterpart
of the functional diarrhoea in adults. According to the Rome III criteria, chronic nonspeciﬁc diarrhoea is
deﬁned as toddler’s diarrhoea in children younger than four years and as irritable bowel syndrome in
the age range of 5–18 years; the two deﬁnitions are rather distinct [2]. Also the clinical hallmarks of
chronic diarrhoea may be different in adults and children, who require an age-targeted approach. In
addition, the diagnostic work up in children is hampered by the need to limit invasive procedures and
by the interpretation of reported symptoms, which may be difﬁcult in young children.
In this paper we present themain features of childhood diarrhoea and suggest a stepwise diagnostic
approach, which includes noninvasive intestinal function tests. The use of the latter may limit
unnecessary endoscopic procedures thereby resulting in less stressful management of children. We
also describe congenital diarrhoeal disorders, a group of severe and rare conditions that are speciﬁc to
early infancy and require a tertiary care centre for diagnosis and treatment [3].
The aetiology of chronic diarrhoea in children
The main causes of chronic diarrhoea in children are listed in Table 1. The aetiology of chronic
diarrhoea is strongly determined by socio-economic factors and by the clinical setting. In developing
countries, chronic diarrhoea is frequently caused by infections; malnutrition is a major risk factor for
a protracted course [4]. The most common etiologies of chronic diarrhoea in developed countries are
functional intestinal disorders, nutrient malabsorption, and inﬂammatory bowel diseases (IBD), but
persistent infections of the intestinal tract are also common. There are also many other less common
causes of chronic diarrhoea. However, as shown in Table 2, the spectrum of aetiology is largely age-
dependent and many conditions are virtually exclusive, or conﬁned to, speciﬁc age ranges.
Intestinal infections are always a potential aetiology of chronic diarrhoea and selected agents show
a peculiar distribution. Entero-adherent Escherichia coli and Cryptosporidium parvum have beenTable 1
Main causes of chronic diarrhoea in children.
Infectious aetiologies:
Bacterial, viral and protozoan agents, small intestinal bacterial overgrowth, post-enteritis syndrome, tropical sprue, Whipple
disease
Non-infectious aetiologies:
Diarrhoea associated with exogenous substances: Excessive intake of carbonated ﬂuid, dietetic foods containing sorbitol,
mannitol or xylitol; excessive intake of antiacids or laxatives containing lactulose or Mg(OH)2; excessive intake of
methylxanthines-containing drinks (cola, tea, coffee); NSAIDs.
Abnormal digestive processes: Cystic ﬁbrosis, Shwachman–Diamond syndrome, isolated pancreatic enzyme deﬁciency,
chronic pancreatitis, Johanson–Blizzard Syndrome, Pearson syndrome. Trypsinogen and enterokinase deﬁciency: chronic
cholestasis, use of bile acids sequestrants, primary bile acid malabsorption, terminal ileum resection.
Nutrient malabsorption: Congenital or acquired sucrase-isomaltase deﬁciency; congenital or acquired lactase deﬁciency;
glucose-galactose malabsorption; fructose malabsorption, congenital or acquired short bowel
Immune/inﬂammatory: Food allergy; coeliac disease; eosinophilic gastroenteritis, inﬂammatory bowel diseases,
autoimmune enteropathy, primary and secondary immunodeﬁciencies, IPEX syndrome.
Structural defects: Microvillus inclusion disease, tufting enteropathy, phenotypic diarrhoea, heparan-sulphate deﬁciency,
a2b1 and a6b4 integrin deﬁciency, lymphangiectasia.
Defects of electrolyte and metabolite transport: Congenital chloride diarrhoea, congenital sodium diarrhoea,
acrodermatitis enteropathica, selective folate deﬁciency, abetalipoproteinemia.
Motility disorders: Hirschsprung’s disease, chronic intestinal pseudoobstruction (neurogenic and myopathic),
thyrotoxicosis.
Neoplastic diseases: Neuroendocrine hormone-secreting tumours: APUDomas (Amine Precursor Uptake and
Decarboxylation) such as VIPoma (Vasoactive intestinal polypeptide), Zollinger- Ellison and mastocytosis.
Chronic non-speciﬁc diarrhoea: Functional diarrhoea, toddler’s diarrhoea, irritable bowel syndrome.
Table 2
Main causes of chronic diarrhoea according to the age of onset.
0–30 Days 1–24 Months 2–18 Years
Abetalipoproteinemia
Acrodermatitis enteropathica
Autoimmune enteropathy
Congenital chloride Diarrhoea (CLD)
Congenital sodium diarrhoea (CDS)
Congenital short-bowel syndrome
Congenital lactase deﬁciency
Disaccharide intolerance
Food allergy
Glucose-galactose malabsorption
Hirschsprung’sdisease
Immunodysregulation, polyendocrinopathy
and enteropathy
Lysinuric protein intolerance
Malrotation with partial blockage
Microvillous inclusion disease (MID)
Neonatal lymphangiectasia
Primary bile-salt malabsorption (PBAM)
Tufting enteropathy
Intestinal pseudoobstruction
Apple juice and pear nectar
Autoimmune enteropathy
Chronic infection by C. difﬁcile,
G. lamblia
Chronic non-speciﬁc diarrhoea
Coeliac disease
Cystic ﬁbrosis
Food allergy
Post-gastroenteritis diarrhoea
Apple juice or pear nectar
Antibiotic-associated
C. difﬁcile colitis
Chronic infection by
C. difﬁcile, G. lamblia.
Coeliac disease
Irritable bowel syndrome
Inﬂammatory bowel disease
Lactose intolerance
Post-gastroenteritis diarrhoea
A. Guarino et al. / Best Practice & Research Clinical Gastroenterology 26 (2012) 649–661 651implicated in potentially severe chronic diarrhoea in developing countries. In developed countries,
chronic infectious diarrhoea usually runs a benign course. Rotavirus and Norovirus are frequently
involved, whereas Cytomegalovirus and Clostridium difﬁcile are emerging agents of severe diarrhoea in
selected populations. Opportunistic microorganisms in speciﬁc populations, such as immunocom-
promised children, can cause chronic and severe diarrhoea. However different conditions are associ-
atedwith speciﬁc microorganisms. Cryptosporidiosis is themost frequent cause of chronic diarrhoea in
children with HIV infection who have no access to antiretroviral combination therapy, but HIV virus
also may be directly responsible for diarrhoea and for the so called HIV-enteropathy through a direct
effect on the enterocyte involving a redox –mediatedmechanism [5–7]. An entirely different pattern of
agents is found in IBD and several enteric agents may trigger relapses in these children (Table 3).
A common syndrome of chronic diarrhoea is small intestinal bacterial overgrowth, in which diar-
rhoea may be the result of either a direct microorganism/enterocyte interaction or the consequence of
deconjugation and dehydroxylation of bile salts, and hydroxylation of fatty acids due to an abnormal
proliferation of bacteria in the proximal intestine. Bacterial overgrowth may be difﬁcult to detect as
hydrogen breath test is still poorly standardized in children [8]. Postenteritis syndrome is a clinical-
pathological condition in which diarrhoea persists following an acute onset intestinal infection.Table 3
The etiologic spectrum of chronic diarrhoea is completely different children with AIDS.
Children with AIDS Children with IBD
 Cryptosporidium
 Clostridium difﬁcile
 Cytomegalovirus
 Campylobacter spp.
 Entamoeba histolytica
 Enteric viruses
 Giardia lamblia
 Isospora belli
 Mycobacterium avium intracellulare
 Microsporidia
 Salmonella spp.
 Shigella spp.
 Strongyloides
 HIV virus
 Clostridium difﬁcile
 Aeromonas
 Campylobacter
 E. coli O157:H7
 Giardia lamblia
 Plesiomonas
 Salmonella
 Shigella
 Yersinia
 Adenovirus
 Cytomegalovirus
 Rotavirus (group A)
A. Guarino et al. / Best Practice & Research Clinical Gastroenterology 26 (2012) 649–661652Sensitization to food antigens, secondary disaccharidase deﬁciency reinfections or a change in the
microbiota may be responsible for postenteritis syndrome.
A reduction of intestinal absorptive surface is responsible for diarrhoea in coeliac disease, a genetic
intolerance to gluten that affects as many as one in 100 normal subjects, depending on geographic
origin. Gluten intolerance causes villous atrophy leading to a reduction of functional absorptive surface
area that is reversible upon gluten free diet.
Food allergies may present with chronic diarrhoea through a non-IgE-mediated mechanism,
especially during infancy [9]. Eosinophilic gastroenteritis is characterized by eosinophilic inﬁltration of
the intestinal wall and is strongly associated with atopy.
In older children and adolescents, inﬂammatory bowel diseases (IBD), including Crohn’s disease,
ulcerative colitis and indeterminate colitis, are major causes of chronic diarrhoea.
Chronic diarrhoeamay be themanifestation ofmaldigestion due to exocrine pancreatic disorders. In
most patients with cystic ﬁbrosis, pancreatic insufﬁciency results in fat and protein malabsorption. In
Shwachman–Diamond syndrome, exocrine pancreatic hypoplasia may be associated with neutropenia,
bone changes, and intestinal protein loss. Speciﬁc pancreatic enzyme defects result in fat and/or
protein malabsorption. Familial pancreatitis associated with a mutation in the trypsinogen gene may
be associated with pancreatic insufﬁciency and chronic diarrhoea.
Liver disorders may lead to a reduction in the bile salts resulting in fat malabsorption. Bile acid loss
may be associated with terminal ileal diseases, such as Crohn’s disease or following ileal resection. In
primary bile acid malabsorption, neonates and young infants present with chronic diarrhoea and fat
malabsorption due to mutations of ileal bile transporter.
The most benign aetiology of chronic diarrhoea in children is chronic non-speciﬁc diarrhoea which
encompasses functional diarrhoea (or toddler’s diarrhoea) in subjects below four years of age and
irritable bowel syndrome in those aged 5–18 years [2]. The disease is the same, but presentation varies
with age: abdominal pain is more frequent and clearly associated with diarrhoea in older than in
younger children (Table 4). The hallmark of the syndrome is diarrhoea associated with normal weight
growth in well-appearing subjects.Table 4
Age-related Rome III criteria for functional diarrhoea.
Age Criteria
Neonate and Toddlers (below 4 years):
diagnostic criteria for functional diarrhoea
1. Daily painless, recurrent passage of three or more large,
unformed stools;
2. Symptoms that last more than four weeks;
3. Onset of symptoms that begins between 6 and 36 months
of age;
4. Passage of stools that occurs during waking hours;
5. There is no failure-to-thrive if caloric intake is adequate
Child and Adolescent (5 to 18 years):
diagnostic criteriaa for irritable bowel
syndrome
1. Abdominal discomfort (an uncomfortable sensation not
described as pain) or pain associated with two or more of
the following at least 25% of the time:
a) Improved with defecation
b) Onset associated with a change in frequency of stool
c) Onset associated with a change in form (appearance)
of stool
2. No evidence of an inﬂammatory, anatomic, metabolic,
or neoplastic process that explains the subject’s symptoms
Adults (older than 18 years): diagnostic criteriab
for irritable bowel syndrome
Recurrent abdominal pain or discomfortc at least three days per
month in the last three months associated with two or more of
the following:
1. Improved with defecation
2. Onset associated with a change in frequency of stool
3. Onset associated with a change in form (appearance) of stool
a Criteria fulﬁlled at least once per week for at least two months before diagnosis.
b Criteria fulﬁlled for the last three months with symptom onset at least six months prior to diagnosis.
c Discomfort means an uncomfortable sensation not described as pain. In pathophysiology research and clinical trials, a pain/
discomfort frequency of at least 2 day a week during screening evaluation for subject eligibility.
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called congenital diarrhoeal disorders (CDD) that often present in newborns [3,10,11]. Selected causes
of CDD lead to the intractable diarrhoea syndrome, which is often the result of a defect in the structure
of the intestine or of the enterocyte, leading to progressive, often irreversible intestinal failure, which
requires parenteral nutrition for survival.
The approach to children with chronic diarrhoea is strongly driven by the clinical setting and the
patient population. Fig. 1 shows the pattern of aetiology of a population of children seen at a referral
centre.Diagnostic approach to the child with chronic diarrhoea
Similar to adults, endoscopy and histology are often crucial in the diagnostic approach. However, in
children it is important to minimize the invasive tests. Evaluation of a child with chronic diarrhoea
should start with four main clinical features: the age of the child, pattern of weight loss or gain, the
character of the stools (i.e. watery malabsorptive, inﬂammatory) and any associated symptoms. A
careful history and physical examination are the cornerstones of diagnostic approach, including the age
of onset, and whether it was abrupt or gradual. These clinical features are used to plan a diagnostic
algorithm.
A family history is important to assess the possibility of inherited conditions. Most infants and
children with food allergy come from atopic families, and commonly the parents themselves had
vomiting and diarrhoeawhen exposed to particular foods in childhood. Many infants and childrenwith
coeliac disease come from families with other affected members or have relatives with dermatitis
herpetiformis. Other inherited conditions are cystic ﬁbrosis and IBD. Many CDD conditions (i.e.
microvillous inclusion disease) are associated with consanguinity.
A major issue in the initial approach is growth and nutritional assessment. Although there are many
ways to perform a nutritional assessment, weight for height is the simplest index of growth failure
secondary to malnutrition. Sequential height and weight records, with measurement of head circum-
ference, are critical to determine whether, and towhat extent, the disease has impaired growth. Height
is generally involved later thanweight in chronic diarrhoea and its impairment suggests a long standing
condition. The weight curve can range from normal or even excessive growth in diarrhoea due to
overfeeding, to an arrest or decrease in malnutrition and stunted growth in conditions such as coeliac
disease, and delayed growth velocity and puberty in Crohn’s disease. Poor weight gain may be due to
malabsorption, low intake, or can be secondary to changes in metabolism, as in hyperthyroidism. Poor
growth may be due to feeding a dilute hypocaloric formula or clear liquids in an effort to reduce
diarrhoea. Stool features (watery, presence of blood andmucus, presence or absence of undigested food28%
24%
8%
8%
14%
8%
1%
9% Functional diarrhea*
Inflammatory bowel
diseases
Celiac disease
Post-enteritis diarrhea
Alimentary
allergy/intolerance
Infectious diarrhea
Congenital diarrhea
No diagnosis
* Diagnostic approach according to age (Rome III Criteria)  
Fig. 1. Main aetiological groups of chronic diarrhoea in population of 354 children consecutively seen at a tertiary care centre of
gastroenterology in Europe.
A. Guarino et al. / Best Practice & Research Clinical Gastroenterology 26 (2012) 649–661654particles, steatorrhoea) may aid in establishing the pathophysiology of diarrhoea which could be
secretory, inﬂammatory, osmotic, malabsorptive, or functional in nature. Stool frequency and volume
may aid in establishing the diarrhoea severity. If the patient has been admitted to the hospital and has
been electrolyte depleted and dehydrated on one or more occasions, a serious diagnosis should be
considered. If a child or a teenager wakes up at night to defecate or becomes incontinent, an organic
basis for diarrhoea is likely. The presence of blood and/or mucus in the stools suggests intestinal
inﬂammation and possibly IBD. On the contrary, indicators of a functional aetiology are a long duration
of symptoms, the lack of signiﬁcant weight loss, and absence of nocturnal diarrhoea. The Rome III
diagnostic criteria are helpful to make a ﬁnal diagnosis in these cases (Table 4). Vomiting may indicate
intestinal dismotility, due to either mucosal or bowel-wall disease or adhesions from previous surgery,
but is frequently a sign of food intolerance or – less frequently – is associated with an extraintestinal
conditions, such as urinary tract infection, that may induce diarrhoea. Abdominal distension could be
secondary to true obstruction, pseudo-obstruction, malabsorption, or hypersecretion of liquids in the
intestine. A review of any systemic or extraintestinal signs and symptoms is useful in search for other
diagnostic clues. The presence of fever is more typical of infectious or inﬂammatory processes.
Arthralgias, arthritis, uveitis, pyoderma gangrenosum, and hepatitis are all indications of IBD. Recurrent
respiratory tract infections may suggest cystic ﬁbrosis, or immunodeﬁciency.
In infants with chronic diarrhoea, a thorough feeding history must be obtained. The type of milk
formula and the reaction to its initial administration should be determined. If the infant is or was
breast-fed when diarrhoea began, a careful history of the mother’s diet must be determined, especially
looking for any response in the infant’s symptoms to changes in the mother’s diet. The age at which
juice, fruit and gluten-containing products were added should be noted in these infants, and correlated
with symptoms. Onset of diarrhoea soon after fruit and juice are added is typical of sucrase-isomaltase
deﬁciency. On the contrary, symptoms of coeliac disease may not develop for weeks, months, or even
years after gluten is added to the diet.
The initial approach may provide clues for aetiology and help design a rational plan of investiga-
tions. In children with normal weight growth, the most probable cause is functional diarrhoea.
However it is important that the conditions meet the age-speciﬁc criteria for functional diarrhoea
listed in Table 4, in order to obtain a reliable diagnosis. Functional diarrhoea only requires monitoring,
and parents need to be reassured of the benign outcome of the condition.
If the stools do not contain occult or gross blood, white blood cells or eosinophils, an inﬂammatory
or food allergy could be reasonably excluded.
Large volumes of loose stools with steatorrhoea indicate nutrient malabsorption or maldigestion.
Coeliac disease is the single most frequent cause of chronic malabsorptive diarrhoea; serology (IgA
anti-tissue transglutaminase type 2 antibody and endomysial antibodies) is a needed test in children of
any age on gluten containing diet, as indicated by current guidelines [12].
In children with weight loss, the diagnostic work up should start with noninvasive tests to evaluate
the digestive and absorptive functions and the presence of inﬂammation (Table 5). Nutrient absorption
tests (Table 5A) are generally performed on stools and provide information on the integrity of small
bowel functions. Conversely, increased markers of inﬂammation (Table 5B), reﬂect intestinal inﬂam-
mation, which is often of colonic origin. Fecal calprotectin, a protein in neutrophils, is not a colonic
speciﬁc marker. However if combined with measurement of nitric oxide in the ﬂuid obtained fromTable 5A
Non-invasive tests for intestinal digestive-absorptive functions.
Test Normal values Implication
a1-antitrypsin fecal concentration <0.9 mg/g stool Increased intestinal permeability/
protein loss
Steatocrit <2.5% (older than 2 years) Fecal fat loss, maldigestion
Fecal reducing substances Absent Carbohydrates malabsorption
Elastase concentration >200 mg/g stool Exocrine pancreatic dysfunction
Chymotrypsin concentration >7.5 U/g
>375 U/24 h
Exocrine pancreatic dysfunction
Dual sugar (cellobiose/mannitol) absorption test Urine excretion ratio: 0.010  0.018 Increased small bowel permeability
Table 5B
Non-invasive tests for intestinal inﬂammation.
Test Normal values Implication
Fecal occult blood Absent Fecal blood loss
Fecal calprotectin concentration <100 mg/g for children aged >12 m Intestinal inﬂammation
Fecal leukocytes <5/microscopic ﬁeld Colonic inﬂammation
Nitric oxide in rectal dyalisate <5 mM of NO2/NO3 Localizes inﬂammation in the rectum
A. Guarino et al. / Best Practice & Research Clinical Gastroenterology 26 (2012) 649–661 655a small bag placed in the rectum (rectal dialysis bag), it quite reliably reﬂects distal intestinal
inﬂammation [13]. Fecal calprotectin may be therefore a screening test, alone or in combination with
other noninvasive tests, to determine if colonoscopy is indicated [14].
Overall, noninvasive tests in chronic diarrhoea provide clues to detect aetiology and plan subse-
quent diagnostic work up. Generally abnormalities in nutrient absorption tests may indicate a need for
upper endoscopy whereas inﬂammation suggests to proceed with rectosigmoidoscopy or colonoscopy
(Fig. 2). The use of noninvasive tests in addition to this stepwise approach (Table 6) strongly reduced
the need for invasive investigations and associated costs [15]. While upper or lower endoscopy is often
necessary and should be done in conditions of analgesia appropriate for children’s age [16], it may not
always provide a conclusive diagnosis [17]. Radiology imaging has a role in the diagnostic approach to
children with chronic diarrhoea, but is less important than in adults. Abdominal ultrasound may help
detecting a thickened distal bowel wall suggesting mucosal disease such as Crohn’s disease [14].
Chronic diarrhoea in the neonatal age
Diarrhoea is relatively rare in neonates, but its early onset may be predictive of congenital diar-
rhoeal disorders that may require hospitalization [10]. Several conditions are related to genetic defects.
Thus molecular diagnosis can be helpful also for genetic counselling for the family [18].
Diagnosis depends on determining whether the patient has sufﬁcient functioning bowel for
nutrient digestion and absorption. A major issue is to assess whether the intestinal villi are intact or
congenitally defective, as in microvillous inclusion disease or in tufting enteropathy; or whether thereWeight
loss
Weight loss Fever or 
signs of inflammation
Diagnostic tests to determine 
Specific treatment 
Non invasive intestinal function tests
Malabsorption 
pattern
Inflammatory 
pattern
Upper 
intestinal 
endoscopy
Rectosigmoidoscopy
/ colonoscopy 
Sucrose 
intolerance 
Decrease selected carbohydrate 
Weight and height normal 
Nutritional status normal 
No fat in stools
Chronic
diarrhea 
Chronic non-specific 
diarrhea 
Refer to 
ROME III 
Exclude excessive 
intake of fruit 
Diarrhea related  
to carbohydrate intake
Carbohydrate 
malabsorption 
Lactose 
intolera
Fig. 2. Diagnostic algorithm for children with chronic diarrhoea.
Table 6
Stepwise diagnostic approach to children with diarrhoea.
Step 1 Intestinal microbiology B Stool cultures
B Microscopy for parasites
B Viruses
B H2 breath test
Screening test for coeliac disease:
B Serology according to age and level of IgA (including AGA IgA/IgG, EMA IgA/IgG, tTG IgA/IgG)
Non invasive tests for: B Intestinal function (including double sugar test, xylosemia, iron absorption test)
B Pancreatic function (amylase, lipase, fecal elastase)
B Intestinal inﬂammation (fecal calprotectin, rectal nitric oxide)
Tests for food allergy: B Prick/patch tests for foods
Abdominal Ultrasounds (scan of last ileal loop)
Step 2 Evaluation of intestinal morphology:
B Endoscopy and standard jejunal/colonic histologya
B Morphometry
B PAS staining
B Electron microscopy
Imaging (upper or lower bowel series, capsule endoscopy)
Step 3 Special investigations:
B Intestinal immunohistochemistry
B Anti-enterocyte antibodies
B Serum chromogranin and catecholamines
B Autoantibodies
B 75SeHCAT measurement
B Brush border enzymatic activities
B Motility and electrophysiological studies
a The choice of upper and lower endoscopy may be supported by noninvasive tests From Guarino A and Branski D Nelson
Textbook of Pediatrics XIX Edition (modiﬁed).
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chloride diarrhoea and congenital sodium diarrhoea, respectively. Some patients need small bowel
radiology to assess intestinal length and to look for malrotation. Congenital short-bowel syndrome
may present with malabsorption in the absence of inﬂammatory changes in the stools. If bowel length
appears normal, the patient should have small intestinal biopsies to look for characteristic changes
seen by light and electron microscopy in primary enterocyte abnormalities. Finally an aliquot of
intestinal ﬂuid may be aspirated for quantitative bacterial cultures, and, if indicated, for diagnosis of
small intestinal bacterial overgrowth and pancreatic insufﬁciency.
However, many primary etiologies of neonatal diarrhoea have been identiﬁed and we brieﬂy
summarize them.
Congenital diarrhoeal disorders
Congenital diarrhoeal disorders (CDDs) are a group of rare severe enteropathies [3]. Most CDDs
display a similar clinical presentation despite a different outcome. Therapy should be started soon to
prevent life-threatening complications [19].
We recently proposed a classiﬁcation of CDDs that includes four groups:
i) defects in digestion, absorption and transport of nutrients and electrolytes;
ii) disorders of enterocyte differentiation and polarization;
iii) defects of enteroendocrine cell differentiation;
iv) disregulation of the intestinal immune response.
A. Guarino et al. / Best Practice & Research Clinical Gastroenterology 26 (2012) 649–661 657CDDs are inherited and in most cases the genetic defect is known [19]. However, a speciﬁc CDD is
only rarely diagnosed based on clinical features, when diarrhoea is a symptom of a more complex
syndrome. Furthermore, milder forms of CDDs may remain undiagnosed until adulthood. Therefore
molecular analysis may contribute to rapid and unequivocal diagnosis in a high percentage of CDDs,
and for many frequent disorders, molecular analysis is commercially available [19]. In the majority of
cases, genes responsible for CDD are not particularly large, which allows scanning techniques like gene
sequencing for molecular analysis. Furthermore, selected CDDs in speciﬁc ethnic groups are caused by
a single mutation due to the founder effect, while the same diseases in other ethnic groups may be due
to myriad of different mutations. Among all the diseases listed in Table 7, molecular diagnosis can be
routinely performed inmost, except: (i) congenital MGD, because nomutations have been identiﬁed so
far in the putative disease gene MGAM in affected patients, suggesting that the disease may depend on
other regulatory genes; (ii) FM, in which more genes encoding fructose carriers may be involved; (iii)
CSD, in which only syndromic forms have mutations in the SPINT2 gene; (iv) IPEX-like syndrome, for
which the disease gene is still unknown even if a single patient had a mutation in the CD25 encoding
gene [19]. In some CDDs, like GGM, IPEX, CF and molecular analysis has been used for prenatal diag-
nosis; given the severe outcome of most CDD, and the availability of effective gene scanning, the
request for prenatal diagnosis will increase. Prenatal diagnosis should always be associated with
multidisciplinary counselling to the families [19].
The total number of CDDs has gradually increased, but the incidence of most of them remains to be
established. Apart from the fructose malabsorption (FM) that in Western countries involves up to 40%
of subjects, CDDs are rare [20]. In fact, their incidence ranges between 1:2500 (CF) to 1:5000 (sucrase-
isomaltase deﬁciency, SID) to 1:60.000 (congenital lactase deﬁciency, LD) up to 1:400,000 (Tricho-
Hepato-Enteric, THE syndrome) [21]. For other CDDs, such as polyendocrinopathy, X-linked (IPEX)
syndrome or autoimmune polyglandular syndrome type 1 (APS1), few cases have been described so far,
but the recent identiﬁcation of the disease-genes and the availability of molecular analysis may reveal
a higher incidence [22]. Furthermore, selected CDDs are more frequent in ethnic groups where
consanguineous marriages are common, or in some geographic areas due to founder effects. For
example, congenital LD is particularly frequent in Finland; lysinuric protein intolerance (LPI) has
a higher incidence either in Finland and in Japan due to founder effect, and a speciﬁc mutation is
typically found in each of the two ethnic groups; in southern Italy there are several affected patients,
related to four different kindreds [23]; congenital SID (whose incidence is 1:5000 worldwide) may
affect up to 5% of the population in Greenland, Alaska and Canada [24]. Similarly, CLD is sporadic
worldwide and a large genetic heterogeneity has been reported in the approximately 150 patients
described so far [25] Even if most CDDs are rare, a recent nationwide Italian study estimated an overall
occurrence rate of one per 2000 hospitalized newborns [10]; immune response and altered enterocyte
differentiation and polarization were the most common etiologies [26].
Molecular analysis has changed the diagnostic approach to CDD, leading to a reduction of invasive
and expensive procedures. However, some critical points remain: (i) the molecular analysis should be
based on scanning procedures [27], including the search for large gene deletions [28], using adequate
quality control programs [29] andwell trained technologists; (ii) functional analysis of novel mutations
is needed to demonstrate their pathogenic role; (iii) the negative results of molecular analysis does not
exclude the disease, because mutations may involve non-coding, regulatory areas; high throughput
sequencing could help to perform extensive analyses; however, also if the mutation is not known,
carrier and prenatal diagnosis may be performed using linkage analysis; (iv) some CDD are very rare; it
is necessary that laboratories offer molecular diagnosis also for such ‘orphan’ diseases.
Therapeutic approach to chronic diarrhoea in children
Chronic diarrhoea associated with impaired nutritional status is serious, and therapy should be
started promptly. Treatment includes general supportive measures, nutritional rehabilitation, elimi-
nation diets and some drugs. Proabsorptive drugs or hormones (GH, serotonin analogues, acetor-
phane), are used for promoting restoration of disrupted intestinal epithelium.
Nutritional rehabilitation is often essential and is based on clinical and biochemical assessment. In
moderate to severe malnutrition, caloric intake may be progressively increased to 50% or more above
Table 7
Inheritance, epidemiology and pathological mechanisms of congenital diarrhoeal disease.
Disease 
                             Gene 
 
Name 
 
 
Location 
Transmission and incidence Mechanism 
1) Genes encoding brush-
border enzymes  
Congenital  lactase deficiency 
(LD) LCT  2q21.3 
AR, 1:60.000 in Finland; lower in other 
ethnic groups Osmotic 
Congenital sucrase-isomaltase 
deficiency (SID) SI  3q26.1 
AR, 1:5.000; higher incidence in 
Greenland, Alaska and Canada Osmotic 
Congenital maltase-
glucomaylasedeficiency (MGD) not defined  -- few cases described Osmotic 
2) Genes encoding membrane 
carriers  
Glucose-
galactosemalabsorption (GGM) SLC5A1 22q13.1 AR, few hundred cases described Osmotic 
 citomsO %04 ot pu --  denifed ton )MF( noitprosbalam esotcurF
Fanconi-Bickel syndrome 
(FBS) SLC2A2 3q26.2 
AR, rare, higher frequency in 
consanguineous Osmotic 
Acrodermatitisenteropathica 
(ADE)  citomsO 000.005:1 ,RA 3.42q8 4A93CLS
Congenitalchloridediarrhea 
(CCD, DIAR 1) SLC26A3 7q31.1 AR, sporadic; frequent in some ethnies Osmotic 
Lysinuric protein intolerance 
(LPI) SLC7A7 14q11.2 
AR, about 1:60.000 in Finland and in 
Japan; rare in other ethnic groups Osmotic 
Primary bile acid malabsorption 
(PBAM)  yroterceS RA 1.33q31 2A01CLS
 citomsO 005.2:1 ,RA 2.13q7 RTFC )FC( sisorbif citsyC
3) Genes encoding pancreatic 
enzymes  
 citomsO RA 12q12 7SSRP )DKE( ycneicifed esanikoretnE
Hereditary pancreatitis (HP) 
 
PRSS1 
SPINK1 
7q34 
5q32 
AR, cases with compound mutations in 
different genes; SPINK1 mutations may 
also cause tropical pancreatitis 
Osmotic 
Congenital absence of 
pancreatic lipase (APL)  citomsO -- 3.52q01 PILNP
4) Genes encoding proteins of 
lipoprotein metabolism   
Abetalipoproteinemia (ALP) MTTP 4q27 AR, about 100 cases described; higher frequency among Ashkenazi Osmotic 
Hypobetalipoproteinemia 
(HLP) Apo B 2p24.1 autosomal co-dominant Osmotic 
Chilomicron retention disease 
(CRD) SAR1B 5q31.1 AR, about 40 cases described Osmotic 
5) Genes encoding other typeof 
proteins  
Congenital sodium diarrhea 
(CSD, DIAR 3) 
SPINT2 (only 
syndromic CSD)  citomsO RA 2.31q91
Shwachman-Diamond 
syndrome (SDS)  citomsO RA 11q7 SDBS
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Table 7 (continued )
Disease OMIM number Transmission and incidence Mechanism 
Microvillous Inclusion Disease (MVID, DIAR 2) 251850 AR; rare; higher frequency among Navajo Secretory 
Congenital tufting enteropathy (CTE, DIAR 5) 613217 AR; 1:50-100.000; higher among Arabians Secretory 
yroterceS000.004:1,RA074222)EHT(emordnisciretnE-otapeH-ohcirT
3)Defects of enteroendocrine cells differentiation 
Disease OMIM number Transmission and incidence Mechanism 
Congenital malabsorptivediarrhea (CMD, DIAR 4) 610370 AR; few cases described Osmotic 
citomsORA559006)DCP(ycneicifed3/1esatrevnocnietorporP
4)Defects of modulation of intestinal immune response 
Disease OMIM number Transmission and incidence Mechanism 
Autoimmune polyglandular syndrome type 1 (APS1) 240300 AR; AD (1 family) Secretory 
Immune dysfunction, polyendocrinopathy, X-linked (IPEX) 601410 X linked (autosomal cases described), 
very rare Secretory 
yroterceSdeknil-Xton--emordnysekil-XEPI
2)Defects of enterocyte differentiation and polarization
Modiﬁed from reference [19] with author’s permission: Terrin G, Tomaiuolo R, Passariello A, Elce A, Amato F, Di CostanzoM, et al.
Congenital diarrhoeal disorders: an updated diagnostic approach. Int J Mol Sci 2012;13:4168–85.
A. Guarino et al. / Best Practice & Research Clinical Gastroenterology 26 (2012) 649–661 659the recommended dietary allowances. The intestinal absorptive capacity should be monitored by
digestive function tests. In children with steatorrhoea, medium chain triglycerides may be the main
source of lipids. Lactose-free diet should be started in all children with chronic diarrhoea, as recom-
mended by the WHO [30]. Lactose is generally replaced by maltodextrin or a combination of complex
carbohydrates. Sucrose-free formula is indicated in sucrase-isomaltase deﬁciency. Semi-elemental or
elemental diets have the dual purpose of overcoming food intolerance, which may be the primary
cause of chronic diarrhoea in infants and young children as well as facilitating nutrient absorption. The
sequence of elimination should be graded from less to more restricted diets, i.e. cow’s milk protein
hydrolysate to amino-acid-based formula, depending on the child’s condition. In severely compro-
mised infants it may be reasonable to start with amino-acids-based feeding.
Clinical nutrition can include enteral or parenteral nutrition [31] Enteral nutrition may be per-
formed via nasogastric or gastrostomy tube, and is indicated in a child who is not able to be fed through
the oral route, either because of primary intestinal diseases or because of extreme weakness.
Continuous enteral nutrition is effective in children with a reduced absorptive function, such as short
bowel syndrome, since it extends the time of nutrient absorption through the still functioning surface
area. In extreme wasting, enteral nutrition may not be sufﬁcient and parenteral nutrition is required.
Micronutrient and vitamin supplementation are part of nutritional rehabilitation and prevent
further problems, especially in malnourished children from developing countries [32]. Zinc supple-
mentation is an important factor in both prevention and therapy of chronic diarrhoea, since it
A. Guarino et al. / Best Practice & Research Clinical Gastroenterology 26 (2012) 649–661660promotes ion absorption, restores epithelial proliferation and stimulates immune response. Nutritional
rehabilitation has a general beneﬁcial effect on the patient’s general condition, intestinal function, and
immune response.
Drug therapy includes anti-infectious drugs, immune suppression, and drugs that inhibit ﬂuid loss
and promote cell growth. If a bacterial agent is detected, speciﬁc antibiotics should be prescribed.
Empiric antibiotic therapy may be used in children with either small bowel bacterial overgrowth or
with suspected bacterial or parasitic diarrhoea. In Rotavirus-induced severe and protracted diarrhoea,
oral administration of human immunoglobulins (300 mg/kg) should be considered [33].
Immune suppression should be considered in selected conditions such as autoimmune enteropathy.
Treatment may be also directed at modifying speciﬁc pathophysiologic processes [34]. Severe ion
secretionmay be reduced by pro-absorptive agents, such as the enkephalinase inhibitor racecadotril. In
diarrhoea due to neuroendocrine tumours, microvillus inclusion disease and enterotoxin-induced
severe diarrhoea, a trial with somatostatin analogue octreotide may be considered. Zinc and growth
hormone promote both enterocyte growth and ion absorption and may be effective when intestinal
atrophy and ion secretion are associated. Butyrate has been proposed for the treatment of congenital
chloride diarrhoea [35]. However, when other attempts have failed, the only option may be parenteral
nutrition or intestinal transplantation [36].Conclusions
The etiologies of chronic diarrhoea in children are different from adults. It requires a speciﬁc
diagnostic approach, determined by age and clinical conditions to guide evaluation.
The initial diagnostic approach should be noninvasive and guided by tests that drive the need and
the type of more invasive investigations. Treatment is substantially different with a relatively major
role of nutritional interventions that are essential in a growing child, and to prevent or stop the vicious
cycle of diarrhoea and malnutrition.Practice agenda
– The aetiology and clinical presentation of chronic diarrhoea in children are different from that
observed in adults;
– The diagnostic approach should be noninvasive and driven by intestinal function tests;
– Nutrition has a major role in the treatment of chronic diarrhoea. It includes both nutritional
rehabilitation in malnourished children and exclusion diet in food intolerance.
Research agenda
– Validated noninvasive tests to assess the intestinal function and inﬂammation are strongly
needed.
– Genetic analysis needs to be developed for a better knowledge of etiologies of congenital
diarrhoea
– The role of intestinal pathogens in chronic diarrhoea, and biomarkers to monitor its course,
should be investigated.References
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